<DOC>
	<DOC>NCT02241395</DOC>
	<brief_summary>The purpose of this study was to study the effect of autologous bone marrow mononuclear cells on common symptoms of cerebral palsy patients.</brief_summary>
	<brief_title>Cell Therapy as Treatment for Cerebral Palsy</brief_title>
	<detailed_description />
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<criteria>diagnosed cases of any type of Cerebral Palsy age above 6 months. presence of acute infections such as Human immunodeficiency virus/Hepatitis B Virus/ Hepatitis C Virus malignancies bleeding tendencies pneumonia renal failure severe liver dysfunction severe anemia [Hemoglobin &lt; 8] any bone marrow disorder space occupying lesion in brain other acute medical conditions such as respiratory infection and pyrexia.</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Cerebral Palsy</keyword>
	<keyword>autologous bone marrow mononuclear cells</keyword>
	<keyword>stem cell</keyword>
</DOC>